| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on ,
Accepted on ,
Cancer Diagnostics |
2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer
1 Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, MN
* To whom correspondence should be addressed. E-mail: klee.george{at}mayo.edu.
Background: Zn-
2 glycoprotein (ZAG) is a relatively abundant glycoprotein that has potential as a biomarker for prostate cancer. We present a high-flow liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for measuring serum ZAG concentrations by proteolytic cleavage of the protein and quantification of a unique peptide.
Methods: We selected the ZAG tryptic peptide 147EIPAWVPEDPAAQITK162 as the intact protein for quantification and used a stable isotope-labeled synthetic peptide with this sequence as an internal standard. Standards using recombinant ZAG in bovine serum albumin, 50 g/L, and a pilot series of patient sera were denatured, reduced, alkylated, and digested with trypsin. The concentration of ZAG was calculated from a dose-response curve of the ratio of the relative abundance of the ZAG tryptic peptide to internal standard.
Results: The limit of detection for ZAG in serum was 0.08 mg/L, and the limit of quantification was 0.32 mg/L with a linear dynamic range of 0.32 to 10.2 mg/L. Replicate digests from pooled sera run during a period of 3 consecutive days showed intraassay imprecision (CV) of 5.0% to 6.3% and interassay imprecision of 4.4% to 5.9%. Mean (SD) ZAG was higher in 25 men with prostate cancer [7.59 (2.45) mg/L] than in 20 men with nonmalignant prostate disease [6.21 (1.65) mg/L, P = 0.037] and 6 healthy men [3.65 (0.71) mg/L, P = 0.0007].
Conclusions: This LC-MS/MS assay is reproducible and can be used to evaluate the clinical utility of ZAG as a cancer biomarker.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  D. M. Selva, A. Lecube, C. Hernandez, J. A. Baena, J. M. Fort, and R. Simo Lower Zinc-{alpha}2-Glycoprotein Production by Adipose Tissue and Liver in Obese Patients Unrelated to Insulin Resistance J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4499 - 4507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Keshishian, T. Addona, M. Burgess, D. R. Mani, X. Shi, E. Kuhn, M. S. Sabatine, R. E. Gerszten, and S. A. Carr Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution Mol. Cell. Proteomics, October 1, 2009; 8(10): 2339 - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Seegmiller, D. R. Barnidge, B. E. Burns, T. S. Larson, J. C. Lieske, and R. Kumar Quantification of Urinary Albumin by Using Protein Cleavage and LC-MS/MS Clin. Chem., June 1, 2009; 55(6): 1100 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kuhn, T. Addona, H. Keshishian, M. Burgess, D.R. Mani, R. T. Lee, M. S. Sabatine, R. E. Gerszten, and S. A. Carr Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Clin. Chem., June 1, 2009; 55(6): 1108 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. deWilde, K. Sadilkova, M. Sadilek, V. Vasta, and S. H. Hahn Tryptic Peptide Analysis of Ceruloplasmin in Dried Blood Spots Using Liquid Chromatography-Tandem Mass Spectrometry: Application to Newborn Screening Clin. Chem., December 1, 2008; 54(12): 1961 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Hoofnagle, J. O. Becker, M. H. Wener, and J. W. Heinecke Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry Clin. Chem., November 1, 2008; 54(11): 1796 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Hortin, D. Sviridov, and N. L. Anderson High-Abundance Polypeptides of the Human Plasma Proteome Comprising the Top 4 Logs of Polypeptide Abundance Clin. Chem., October 1, 2008; 54(10): 1608 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. A. Daniel, C. Turner, R. M. Haynes, B. J. Hunt, and R. N. Dalton Quantification of Hemoglobin A2 by Tandem Mass Spectrometry Clin. Chem., August 1, 2007; 53(8): 1448 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Gundry and J. E. Van Eyk Unraveling the Complexity of Circulating Forms of Brain Natriuretic Peptide Clin. Chem., July 1, 2007; 53(7): 1181 - 1182. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Hortin A New Era in Protein Quantification in Clinical Laboratories: Application of Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., April 1, 2007; 53(4): 543 - 544. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
